IL7 and colorectal cancer: Reprogrammed interleukin-7 (IL-7)-IL-12-MSCs are reported to promote the activation of CAR-T immune cells and the release of IFN-γ and tumor necrosis factor-α (TNF-α), which markedly enhanced colorectal cancer cell death (10).